000 | 01818 a2200457 4500 | ||
---|---|---|---|
005 | 20250517113452.0 | ||
264 | 0 | _c20180521 | |
008 | 201805s 0 0 eng d | ||
022 | _a2045-2322 | ||
024 | 7 |
_a10.1038/srep32493 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAgatheeswaran, S | |
245 | 0 | 0 |
_aIdentification and functional characterization of the miRNA-gene regulatory network in chronic myeloid leukemia lineage negative cells. _h[electronic resource] |
260 |
_bScientific reports _c09 2016 |
||
300 |
_a32493 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_a3' Untranslated Regions _xgenetics |
650 | 0 | 4 |
_aAdaptor Proteins, Signal Transducing _xgenetics |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 |
_aCell Lineage _xdrug effects |
650 | 0 | 4 |
_aG1 Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 |
_aG2 Phase Cell Cycle Checkpoints _xdrug effects |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 |
_aGene Expression Regulation, Leukemic _xdrug effects |
650 | 0 | 4 |
_aGene Regulatory Networks _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImatinib Mesylate _xpharmacology |
650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xdrug therapy |
650 | 0 | 4 |
_aMicroRNAs _xgenetics |
650 | 0 | 4 |
_aNeoplastic Stem Cells _xdrug effects |
650 | 0 | 4 |
_aNuclear Proteins _xgenetics |
650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 | _aReal-Time Polymerase Chain Reaction |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 |
_acdc25 Phosphatases _xmetabolism |
700 | 1 | _aPattnayak, N C | |
700 | 1 | _aChakraborty, S | |
773 | 0 |
_tScientific reports _gvol. 6 _gp. 32493 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/srep32493 _zAvailable from publisher's website |
999 |
_c26382682 _d26382682 |